IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2/3 biotech developing antibody therapies to treat and prevent COVID-19.
Industry: Health Care
Latest Trade: $2.15 0.00 (0.0%)
First Day Return: +22.8%
Return from IPO: -87.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/16/2021 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 18.2 |
Deal Size ($mm) | $309 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/05/2021 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 18.2 |
Deal Size ($mm) | $309 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2020 |
Employees | 68 |
Website adagiotx.com |